FDA Matters logo
  • Blog
  • About
  • Media
“Me, FDA, and Maybe the Mafia”–A Tribute to the FDA Inspectors Who Keep Us Safe

“Me, FDA, and Maybe the Mafia”–A Tribute to the FDA Inspectors Who Keep Us Safe

by Steven A. Grossman | Dec 19, 2025 | Short Takes and Updates

FDA Is Built on Predictability and Expertise, Not Norm-Breaking

FDA Is Built on Predictability and Expertise, Not Norm-Breaking

by Steven A. Grossman | Dec 11, 2025 | Short Takes and Updates

Post-Thanksgiving Analysis: Hot Questions and Intriguing Answers

Post-Thanksgiving Analysis: Hot Questions and Intriguing Answers

by Steven A. Grossman | Dec 2, 2025 | Short Takes and Updates

Once Again, It’s Time to Give Thanks to FDA

Once Again, It’s Time to Give Thanks to FDA

by Steven A. Grossman | Nov 26, 2025 | Short Takes and Updates

Once Again, It’s Time to Give Thanks to FDA

Dr. Pazdur’s New Role at CDER: More Than Just Adding Stable Leadership

by Steven A. Grossman | Nov 19, 2025 | Short Takes and Updates

Once Again, It’s Time to Give Thanks to FDA

Morale at FDA: Ready to Rebound or On a Downward Spiral?

by Steven A. Grossman | Nov 11, 2025 | Short Takes and Updates

Over the past two weeks, several news stories have reported low morale at FDA. Although they all reached the same conclusion, each story focused on a different driver. One was about how the shutdown was exacerbating low morale; another focused on the cumulative impact...
« Older Entries
Next Entries »

Recent Posts

  • New Op-Ed: Here’s How the Blue Tsunami Will Turn the Healthcare Tide
  • Public Health and the Midterm Elections– A Field Guide
  • Can the Midterms Save Vaccines? Don’t Count on It.
  • Leading FDA Is an Impossible Job Right Now. Heidi Overton Could Still Do It Well.
  • Chairman Cassidy: Please Ask Dr. Overton About FDA Decision-Making

Recent Comments

No comments to show.
FDA Matters logo

 ©2009-2026 FDA Matters | FDA Matters does not report the news….we provide analysis of what’s behind the news.

We sometimes use artificial intelligence in drafting columns, primarily using Claude AI and Microsoft Co-Pilot. We review and verify all findings, interpretations, and final wording.